|
Status |
Public on Nov 05, 2012 |
Title |
Patient 21 pre-treatment serum |
Sample type |
protein |
|
|
Source name |
Serum
|
Organism |
Homo sapiens |
Characteristics |
cancer: hormone refractory prostate cancer designation: Non-responder treatment status: pre protein: Human IgG
|
Extracted molecule |
protein |
Extraction protocol |
Serum was obtained from the supernatant of whole blood with the red blood cells spun down and was frozen in aliquots and stored at -80C. Protein is purified from baculovirus using either GST or His tags.
|
Label |
Alexafluor 647
|
Label protocol |
Commercially available anti-human IgG conjugated with Alexafluor647 was purchased from Invitrogen.
|
|
|
Hybridization protocol |
Serum was diluted 1:500 and used to hybridize Invitrogen protoarray v4.0. Bound antibodies were detected with anti-human IgG conjugated with Alexafluor 647.
|
Scan protocol |
Arrays were scanned with an Axon scanner.
|
Description |
Serum was diluted 1:500 and used to hybridize Invitrogen protoarray v4.0. Bound antibodies were detected with anti-human IgG conjugated with Alexafluor 647. Array was scanned with an Axon scanner.
|
Data processing |
The raw data for all arrays were quantile-normalized, median-centered, and log2 transformed using R version 2.14.1
|
|
|
Submission date |
Jul 26, 2012 |
Last update date |
Nov 05, 2012 |
Contact name |
Serena S Kwek |
E-mail(s) |
serena.kwek@ucsf.edu
|
Phone |
4155149301
|
Organization name |
UCSF
|
Department |
Medicine
|
Lab |
Hem/Onc
|
Street address |
513 Parnassus Ave.
|
City |
San Francisco |
State/province |
CA |
ZIP/Postal code |
94143 |
Country |
USA |
|
|
Platform ID |
GPL15855 |
Series (1) |
GSE39688 |
Immune response biomarker profiling of serum from prostate cancer patients treated with anti-CTLA-4 immunotherapy. |
|